covid19
#SanofiActs
2020-03-30LL

First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

covid19
#SanofiActs
2020-03-27LL

Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19

When cancer grows old
#SanofiActs
2020-03-23LL

Sanofi Mobilizes to Develop a Vaccine against COVID-19

Q4 2019 results

Sanofi's Response in the Fight against COVID-19



Voices from the lab : Nadine Biesemann

5 Questions about Hydroxychloroquine and COVID-19

5 things you need to know - Risk of heart Disease

Sanofi’s Industrial Affairs Teams Carry on in the Face of COVID-19

 
AG 2020

2020 General Meeting

The Sanofi General Meeting will be held on April 28, 2020

Real-World Evidence Turns Experience into Knowledge

2019 Integrated Report: Our Responsibility for the Future




  • Camera
    Press releases
    2020-04-03MMMM DD YYYY
    Sanofi: Availability of the Pre-quarterly Results Communication

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK